Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001644338-21-000002
Filing Date
2021-03-24
Accepted
2021-03-24 16:20:12
Documents
1
Effectiveness Date
2021-03-24
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7825
  Complete submission text file 0001644338-21-000002.txt   8826
Mailing Address 50 ROWES WHARF BOSTON MA 02110
Business Address 50 ROWES WHARF BOSTON MA 02110 617-571-6800
Vigeo Therapeutics, Inc. (Filer) CIK: 0001644338 (see all company filings)

EIN.: 461204256 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-393410 | Film No.: 21768431